Peter Keeling is the Founder and Board Chair of Diaceutics PLC, focusing on solving inefficiencies in the precision medicine diagnostic ecosystem. Educated at Queens University Belfast and MIT, he is a strategist in the pharmaceutical industry, aiming to ensure patients get optimal testing and treatment.
Public information centers on his professional mission, which he pursues with a notable passion and intensity. He founded Diaceutics and a prior diagnostics company, showing a long-standing entrepreneurial drive to fix systemic healthcare challenges and improve patient outcomes.
He developed DXRX, the worlds first diagnostic commercialization platform, to connect labs, pharma, and diagnostic companies and accelerate patient access to precision therapies.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.